Instil Bio, Inc. (TIL)
NASDAQ: TIL · Real-Time Price · USD
7.83
-0.01 (-0.13%)
At close: May 5, 2026, 4:00 PM EDT
7.68
-0.15 (-1.92%)
After-hours: May 5, 2026, 4:06 PM EDT
Instil Bio Market Cap
Instil Bio has a market cap or net worth of $53.1 million as of May 5, 2026. Its market cap has decreased by -47.61% in one year.
Market Cap
53.10M
Enterprise Value
62.15M
1-Year Change
-47.61%
Ranking
Category
Stock Price
$7.83
Market Cap Chart
Since the IPO on March 19, 2021, Instil Bio's market cap has decreased from $2.52B to $53.10M, a decrease of -97.89%. That is a compound annual growth rate of -52.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 53.17M | -28.73% |
| Dec 31, 2025 | 74.60M | -40.12% |
| Dec 31, 2024 | 124.58M | 151.37% |
| Dec 29, 2023 | 49.56M | -39.38% |
| Dec 30, 2022 | 81.76M | -96.29% |
| Dec 31, 2021 | 2.21B | -12.33% |
| Mar 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MiNK Therapeutics | 57.60M |
| iBio, Inc. | 57.11M |
| PDS Biotechnology | 55.82M |
| Kezar Life Sciences | 54.60M |
| Metagenomi Therapeutics | 53.04M |
| Entera Bio | 51.75M |
| Hyperion DeFi | 51.26M |
| Radiopharm Theranostics | 50.84M |